DZ Bank’s Cellebrite CLBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-50,582
Closed -$983K 968
2025
Q1
$983K Buy
50,582
+15,891
+46% +$334K ﹤0.01% 685
2024
Q4
$764K Buy
34,691
+21,053
+154% +$405K ﹤0.01% 690
2024
Q3
$230K Sell
13,638
-30,385
-69% -$451K ﹤0.01% 825
2024
Q2
$526K Buy
44,023
+17,001
+63% +$190K ﹤0.01% 756
2024
Q1
$299K Buy
+27,022
New +$276K ﹤0.01% 825

Other funds holding CLBT

DZ Bank's CLBT Position: Q2 2025 in Review

DZ Bank sold out of Cellebrite (CLBT) in Q2 2025, closing a stake of 50,582 shares — an estimated $983K sold.

DZ Bank first reported a position in CLBT in Q1 2024 and held it in 5 quarters. The position peaked at $983K in Q1 2025. 209 funds tracked by Wall St. Rank hold CLBT as of Q2 2025.

  • DZ Bank reported no remaining Cellebrite position as of Q2 2025 after selling out during the quarter.
  • DZ Bank sold 50,582 Cellebrite shares in Q2 2025, an estimated $983K.
  • DZ Bank first reported a position in Cellebrite in Q1 2024 and held it in 5 quarters.
  • DZ Bank's Cellebrite position peaked at $983K in Q1 2025.
  • 209 funds tracked by Wall St. Rank held Cellebrite as of Q2 2025.

Based on DZ Bank's 13F filing for Q2 2025, filed 14 Aug 2025.